Evidence map›Paper›PMID 40136434›Full record

ArticleCurrent issues in molecular biology2025

Antineoplastic Activity of

Maria Vasiliki Benekou, Panagiota Tzitiridou, Theodora Papagrigoriou, Vasiliki Galani, Chrissa Sioka, Athanassios P Kyritsis, Diamanto Lazari, George A Alexiou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria Vasiliki BenekouNeurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece.ORCID 0009-0005-5569-3056
Panagiota TzitiridouNeurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece.
Theodora PapagrigoriouLaboratory of Pharmacognosy, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0002-6081-7632
Vasiliki GalaniDepartment of Anatomy Histology-Embryology, School of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Chrissa SiokaNeurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0002-2184-4945
Athanassios P KyritsisNeurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0003-0370-1024
Diamanto LazariLaboratory of Pharmacognosy, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.ORCID 0000-0001-8864-131X
George A AlexiouNeurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0003-0257-4481

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GMB) is a remarkably aggressive brain malignancy characterized by high mortality rates, despite continuous advances in therapeutic approaches. Compounds derived from plants are being studied for their potent medicinal properties in the quest for more efficient therapies. This study investigated the anti-glioma properties of

Indexed as

cancerglioblastomagliomaMethyl rosmarinateorganic compoundsThymus thracicus

Identifiers

PMID40136434
PMCPMC11941081

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.